Access the full text.
Sign up today, get DeepDyve free for 14 days.
Kerbel Rs (1979)
Immunologic studies of membrane mutants of a highly metastatic murine tumor.American Journal of Pathology, 97
A. Misra, S. Mulé (1972)
Persistence of Methadone-3H and Metabolite in Rat Brain after a Single Injection and its Implications on Pharmacological ToleranceNature, 238
R. Baker, D. Brunette, R. Mankovitz, L. Thompson, G. Whitmore, L. Siminovitch, J. Till (1974)
Ouabain-resistant mutants of mouse and hamster cells in cultureCell, 1
G. Poste, I. Fidler (1980)
The pathogenesis of cancer metastasisNature, 283
R. Prehn (1976)
Tumor progression and homeostasis.Advances in cancer research, 23
J. Dennis, R. Kerbel (1981)
Characterization of a deficiency in fucose metabolism in lectin-resistant variants of a murine tumor showing altered tumorigenic and metastatic capacities in vivo.Cancer research, 41 1
P. Vischer, W. Reutter (1978)
Specific alterations of fucoprotein biosynthesis in the plasma membrane of Morris hepatoma 7777.European journal of biochemistry, 84 2
G. Klein, E. Klein (1977)
Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts.Transplantation proceedings, 9 1
F. Wiener, E. Fenyö, G. Klein, H. Harris (1972)
Fusion of tumour cells with host cells.Nature: New biology, 238 83
T. Tao, M. Burger (1977)
Non-metastasising variants selected from metastasising melanoma cellsNature, 270
P. Nowell (1976)
The clonal evolution of tumor cell populations.Science, 194 4260
Volker Schirrmacher (1980)
Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis.Immunobiology, 157 2
The evolution towards more aggressive and autonomous behaviour of many cancerous tumours, often referred to as tumour progression1, is thought to stem from the development of heterogeneity within the tumour cell population, combined with the continuous selection of progressively more malignant cellular phenotypes2,3. During the course of the disease, the tumour cells show multiple phenotypic changes in a stepwise, but apparently random fashion, becoming more anaplastic, increasingly independent of growth controls and more metastatic4. Several laboratories, including our own, have analysed aspects of tumour heterogeneity and cancer metastasis by selecting and studying the properties of lectin-resistant (LecR) membrane mutant tumour sublines5–8; in a few cases, such variants have been claimed to be less tumorigenic5,6 or metastatic7,8 than the parental cells from which they were derived. We have attempted to study the factors involved in the reestablishment of tumour heterogeneity by monitoring the stability in vivo of LecR phenotypes of metastatic tumour cells after injection of cloned LecR tumour cells. We now report that spontaneous metastases arising after a subcutaneous (s.c.) injection of cells from variant tumour lines selected from a highly metastatic DBA/2 mouse tumour known as MDAY-D29, and which were stably resistant in tissue culture to wheat germ agglutinin (WGA), no longer carry the WGA-resistant (WGAR) phenotype. The results demonstrate that WGAR tumour cells do not metastasize, but rather, ‘revertants’ for the WGAR phenotype, which presumably were generated in vivo after injection, were the cells actually capable of metastatic growth.
Nature – Springer Journals
Published: Jul 1, 1981
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.